RecruitingNot ApplicableNCT04206215

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Sponsor

Spaulding Rehabilitation Hospital

Enrollment

95 participants

Start Date

Apr 16, 2021

Study Type

INTERVENTIONAL

Conditions

carpal tunnel syndrome Chronic Pain

Summary

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcranial Ultrasound (TUS) and a medical device called transcranial Direct Current Stimulation (tDCS) for people with chronic pain and carpal tunnel syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscranial Direct Current Stimulation (tDCS)

Subjects will receive 20 minutes of either active or sham tDCS at intensity of 2mA. In the sham group, the tDCS device will not be active for the full 20 minutes.

DEVICETranscranial Ultrasound (TUS)

Subjects will receive 20 minutes of either active or sham TUS. During active stimulation the ultrasound will be active for the full 20 minutes- however, during sham stimulation the ultrasound will not be active for the full 20 minutes.